- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
The Changing Faces of Acne : Episode 14
Video
Overview of Isotretinoin MOA and Utilization
Author(s):
Dr Joshua Zeichner reviews the mechanism of action of Isotretinoin and highlights utilization requirements in patients prescribed this treatment.
Video Player is loading.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health
Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025
Expert Insights Into L'Oréal’s Voluntary Recall of Benzoyl Peroxide Products
Advancing Acne Care: New Therapies and Technologies
Balancing Adolescent Acne Treatment and Well-being
Adolescent Acne Management: Strategic Approaches and Leveraging Clascoterone Cream
Comprehensive Acne Management: Exploring the Role of Combination and Food Independent Treatments in an adolescent treatment-naïve patient
Understanding Clascoterone Cream: MOA, Patient Selection Criteria, and Gender-Inclusive Advantages
Navigating Acne Management: Balancing Patient Expectations and Optimizing Skincare Regimens
Critical Insights into Isotretinoin Use: Dietary Considerations and Food-Independent Options
Related Content
